--- title: Insights | Marianne Späne description: Marianne Späne was Siegfried's Chief Business Officer from 2010 until her retirement in 2025. She headed the Siegfried Generics Division from 2008 to 2010. From 2004 to 2008, Marianne managed the Business Development Department and the supply chain for generics. Prior to joining Siegfried, Marianne held various positions with Aceto, a US-based pharmaceutical company, where she developed European expansion strategies, and held the role of Head of the Sales and Marketing of the pharma division of Schweizerhalle. Before joining the pharmaceutical industry, she worked in logistics, business development and as site manager for Boucheron, a cosmetics company. Marianne holds degrees in finance, business administration and marketing from the Business Management School (KFS) in Basel and the Marketing & Business School in Zurich (MBSZ). --- This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. - [Careers](https://www.siegfried.ch/careers/) - [Media](https://www.siegfried.ch/media/) - [Investors](https://www.siegfried.ch/investors/) - [Contact us](https://www.siegfried.ch/contact/) [Company](https://www.siegfried.ch/company/) Company [Purpose](https://www.siegfried.ch/company/purpose/) [Strategy](https://www.siegfried.ch/company/strategy/) [Leadership](https://www.siegfried.ch/company/leadership/) [History](https://www.siegfried.ch/company/history/) [Locations](https://www.siegfried.ch/company/locations/) [Offering](https://www.siegfried.ch/offering/) Offering [Drug Substances](https://www.siegfried.ch/offering/drug-substances/) [Exclusive synthesis](https://www.siegfried.ch/offering/drug-substances/exclusive-synthesis/) [API portfolio](https://www.siegfried.ch/offering/drug-substances/api/) [Reference standards](https://www.siegfried.ch/reference-standards/) [Preclinical and early-phase development](https://content.siegfried.ch/siegfried-acceleration-hub) [Alkaloid raw materials extraction](https://extractas.com.au/) [Drug Products](https://www.siegfried.ch/offering/drug-products/) [Oral solid dosage forms](https://www.siegfried.ch/offering/drug-products/oral-solids/) [Sterile injectables](https://www.siegfried.ch/offering/drug-products/sterile-injectables/) [Ophthalmics](https://www.siegfried.ch/offering/drug-products/ophthalmics/) [Inhalation products](https://www.siegfried.ch/offering/drug-products/inhalatives/) [Viral vectors](https://dinamiqs.com/) [Technologies](https://www.siegfried.ch/technologies/) [Sustainability](https://www.siegfried.ch/sustainability/) Sustainability [People](https://www.siegfried.ch/sustainability/people/) [Environment](https://www.siegfried.ch/sustainability/environment/environment/) [Integrity](https://www.siegfried.ch/sustainability/integrity/) [Quality](https://www.siegfried.ch/sustainability/quality/) [Community engagement](https://siegfried.ch/sustainability/community-engagement/) [Risk management](https://www.siegfried.ch/sustainability/risk-management/) [Insights](https://content.siegfried.ch/insights) [![](https://content.siegfried.ch/hubfs/siegfried-logo.svg)](https://www.siegfried.ch/) What are you looking for? [![](https://content.siegfried.ch/hubfs/siegfried-logo.svg)](https://www.siegfried.ch/) [Company](https://www.siegfried.ch/company/) [Purpose](https://www.siegfried.ch/company/purpose/) [Strategy](https://www.siegfried.ch/company/strategy/) [Leadership](https://www.siegfried.ch/company/leadership/) [History](https://www.siegfried.ch/company/history/) [Locations](https://www.siegfried.ch/company/locations/) [Offering](https://www.siegfried.ch/offering/) [Drug Substances](https://www.siegfried.ch/offering/drug-substances/) [Exclusive synthesis](https://www.siegfried.ch/offering/drug-substances/exclusive-synthesis/) [API portfolio](https://www.siegfried.ch/offering/drug-substances/api/) [Reference standards](https://www.siegfried.ch/reference-standards/) [Preclinical and early-phase development](https://content.siegfried.ch/siegfried-acceleration-hub) [Alkaloid raw materials extraction](https://extractas.com.au/) [Drug Products](https://www.siegfried.ch/offering/drug-products/) [Oral solid dosage forms](https://www.siegfried.ch/offering/drug-products/oral-solids/) [Sterile injectables](https://www.siegfried.ch/offering/drug-products/sterile-injectables/) [Ophthalmics](https://www.siegfried.ch/offering/drug-products/ophthalmics/) [Inhalation products](https://www.siegfried.ch/offering/drug-products/inhalatives/) [Viral vectors](https://dinamiqs.com/) [Technologies](https://www.siegfried.ch/technologies/) [Sustainability](https://www.siegfried.ch/sustainability/) [People](https://www.siegfried.ch/sustainability/people/) [Environment](https://www.siegfried.ch/sustainability/environment/environment/) [Integrity](https://www.siegfried.ch/sustainability/integrity/) [Quality](https://www.siegfried.ch/sustainability/quality/) [Community engagement](https://siegfried.ch/sustainability/community-engagement/) [Risk management](https://www.siegfried.ch/sustainability/risk-management/) [Insights](https://content.siegfried.ch/insights) - [Careers](https://www.siegfried.ch/careers/) - [Media](https://www.siegfried.ch/media/) - [Investors](https://www.siegfried.ch/investors/) - [Contact us](https://www.siegfried.ch/contact/) # Insights ## See our event recap Filter by tags [Technology](https://content.siegfried.ch/insights/tag/technology) [Early-phase development](https://content.siegfried.ch/insights/tag/early-phase-development) [Sustainability](https://content.siegfried.ch/insights/tag/sustainability) [Drug Products](https://content.siegfried.ch/insights/tag/drug-products) [Regulatory support](https://content.siegfried.ch/insights/tag/regulatory-support) [Technology](https://content.siegfried.ch/insights/tag/technology) [Early-phase development](https://content.siegfried.ch/insights/tag/early-phase-development) [Sustainability](https://content.siegfried.ch/insights/tag/sustainability) [Drug Products](https://content.siegfried.ch/insights/tag/drug-products) [Regulatory support](https://content.siegfried.ch/insights/tag/regulatory-support) [Oral solid dosage form](https://content.siegfried.ch/insights/tag/oral-solid-dosage-form) [Scale-up](https://content.siegfried.ch/insights/tag/scale-up) [Dosage Form](https://content.siegfried.ch/insights/tag/dosage-form) [Fill-finish](https://content.siegfried.ch/insights/tag/fill-finish) [Pharmaceutical Manufacturing](https://content.siegfried.ch/insights/tag/pharmaceutical-manufacturing) [Pre-filled syringes](https://content.siegfried.ch/insights/tag/pre-filled-syringes) NEW 01/9/2024 [Technology](https://content.siegfried.ch/insights/tag/technology) ### What to look for in a fill & finish partner [Read article](https://content.siegfried.ch/insights/fill-finish-partner) Recent #### [Sep 28, 2026 Drug Products Oral solid dosage form Accelerating early-stage CMC development for oral drug products](https://content.siegfried.ch/insights/accelerating-early-stage-cmc-development-for-oral-drug-products-1) #### [Aug 19, 2026 Early-phase development Regulatory support More than compliance: Managing the challenges of controlled substance manufacturing](https://content.siegfried.ch/insights/more-than-compliance-managing-the-challenges-of-controlled-substance-manufacturing) #### [Jul 23, 2026 Scale-up Drug Products Dosage form scale-up: Balancing speed and efficiency in later-stage development](https://content.siegfried.ch/insights/dosage-form-scale-up-balancing-speed-and-efficiency-in-later-stage-development) #### Subscribe for more expert insights   All posts ### [Jan 9, 2024 Technology What to look for in a fill & finish partner](https://content.siegfried.ch/insights/fill-finish-partner) Oct 30, 2025 ### Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025 Sign up to stay up to date on Siegfried and our business performance. expect more **Siegfried AG** Untere Brühlstrasse 4 4800 Zofingen, Switzerland [+41 62 746 11 11](tel:+41627461111) [Get in touch](https://www.siegfried.ch/contact-us/) #### About us - [Our company](https://www.siegfried.ch/company/) - [Sustainability](https://www.siegfried.ch/sustainability/) - [Media](https://www.siegfried.ch/media/) - [Investors](https://www.siegfried.ch/investors/) - [Careers](https://www.siegfried.ch/careers/) #### Helpful resources - [Expert insights](https://content.siegfried.ch/insights) - [News archive](https://www.siegfried.ch/news-archive/) - [Reports](https://www.siegfried.ch/investors/investors-download-center-2025/) - [Terms and conditions](https://www.siegfried.ch/terms-and-conditions/) #### Offering - [Drug Substances](https://www.siegfried.ch/offering/drug-substances/) - [Drug Products](https://www.siegfried.ch/offering/drug-products/) - [Technologies](https://www.siegfried.ch/technologies/) 2026 © Siegfried Holding AG - [Privacy Policy](https://www.siegfried.ch/privacy-policy/) - [Legal disclaimer](https://www.siegfried.ch/legal-disclaimer/) - [Imprint](https://www.siegfried.ch/imprint/) ```json { "@context" : "https://schema.org", "@type" : "VideoObject", "contentUrl" : "https://143616667.fs1.hubspotusercontent-eu1.net/hubfs/143616667/Peter%20-%20Video%2001%20Final%20v2.mp4", "dateModified" : "2025-10-31T17:20:09.538Z", "duration" : "PT2M16S", "height" : 1080, "name" : "Peter - Video 01 Final v2", "thumbnailUrl" : "https://143616667.fs1.hubspotusercontent-eu1.net/hubfs/143616667/Peter%20-%20Video%2001%20Final%20v2.mp4/medium.jpg", "uploadDate" : "2025-10-28T21:59:19.239Z", "width" : 1920 } ```